A novel gene therapy against human leukemias : suppression of protein-tyrosine kinase activities
一种针对人类白血病的新型基因疗法:抑制蛋白酪氨酸激酶活性
基本信息
- 批准号:05807092
- 负责人:
- 金额:$ 1.15万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1994
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Protein-tyrosine kinase(PTK)is known to be directly involved in the mechanisms of cell growth or differentiation. As in the case of the Bcr-Abl kinase in chronic myeloid leukemia(CML), activated PTKs have been identified in some human malignancies and shown to participate in the process of oncogenesis. In this study, we have investigated if suppression of such PTK-activities may block the deregulated growth of cancer cells. Tec PTK is known to transduce mitogenic stimuli of cytokines. Addition of antisense oligonucleotides against Tec to culture medium was demonstrated to suppress the cytokine-dependent growth of both leukemia cells and normal bone marrow mononuclear cells. Also, antisense oligonucleotides against Abl could block the growth of CML cell line in a sequence-specific manner.Taken together, suppression of PTK activities should be a novel approach of gene therapy against a broad range of malignancies.
蛋白酪氨酸激酶(PTK)是已知的直接参与细胞生长或分化的机制。与慢性髓性白血病(CML)中Bcr-Abl激酶的情况一样,已在某些人类恶性肿瘤中鉴定出活化的PTK,并显示其参与肿瘤发生过程。在这项研究中,我们研究了抑制这种PTK活性是否可以阻断癌细胞的失调生长。已知Tec PTK是细胞因子的促分裂刺激物。在培养液中加入Tec的反义寡核苷酸,可以抑制白血病细胞和正常骨髓单个核细胞依赖于嘌呤的生长。Abl的反义寡核苷酸能以序列特异性的方式抑制CML细胞株的生长,抑制PTK活性有望成为一种新的基因治疗方法。
项目成果
期刊论文数量(43)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mano, H.al.: "Tec protein-tyrosine kinase is involved in IL-3 signaling pathway." Blood. 85. 343-350 (1995)
Mano, H.al.:“Tec 蛋白酪氨酸激酶参与 IL-3 信号通路。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tang, B.et al.: "Tec kinase associates with c-Kit and is tyrosine phosphorylated and activated following stem cell factor binding." Mol.Cell.Biol.14. 8432-8437 (1994)
Tang, B. 等人:“Tec 激酶与 c-Kit 相关,在干细胞因子结合后被酪氨酸磷酸化并激活。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sato, K.et al.: "Molecular cloning and analysis of the human Tec protein-tyrosine kinase." Leukemia. 8. 1663-1672 (1994)
Sato, K. 等人:“人类 Tec 蛋白酪氨酸激酶的分子克隆和分析。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sasaki, K.et al.: "Coordinate expression of the alpha and beta chains of human granulocyte macrophage colony-stimulating factor receptor confers ligand-induced morphological transformation in mouse fibroblasts." J.Biol.Chem.268. 13697-13702 (1993)
Sasaki, K.等人:“人粒细胞巨噬细胞集落刺激因子受体的α和β链的协调表达在小鼠成纤维细胞中赋予配体诱导的形态转变。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Matsuda, T.et al.: "Association and activation of Btk-Tec kinases by gp130, a signal transducer of the IL-6 family of cytokines." Blood. 85. 627-633 (1995)
Matsuda, T. 等人:“gp130(IL-6 细胞因子家族的信号转导器)对 Btk-Tec 激酶的关联和激活。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MANO Hiroyuki其他文献
MANO Hiroyuki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MANO Hiroyuki', 18)}}的其他基金
Molecular targeted therapy of hematological malignancies based on the genomic information
基于基因组信息的血液恶性肿瘤分子靶向治疗
- 批准号:
17019060 - 财政年份:2005
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Screening of genes specifically activated in the pancreatic juice ductal cells from the patients with pancreatic ductal carcinoma
胰腺导管癌患者胰液导管细胞特异激活基因的筛选
- 批准号:
13670549 - 财政年份:2001
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Isolation of hematopoietic-specific oncogenes by a novel expression screening method
通过新型表达筛选方法分离造血特异性癌基因
- 批准号:
10670964 - 财政年份:1998
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a novel approach to hepatocellular carcinoma
开发治疗肝细胞癌的新方法
- 批准号:
08670616 - 财政年份:1996
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
IND Enabling Non-Clinical Development of E1v1.11, a Morpholino Anti-Sense Oligonucleotide for the treatment of Spinal Muscular Atrophy.
IND 促进 E1v1.11 的非临床开发,E1v1.11 是一种用于治疗脊髓性肌萎缩症的吗啉代反义寡核苷酸。
- 批准号:
10569744 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
Novel Systemic Delivery of Peptide-Mediated Anti-Sense Oligonucleotides for Dementia with Lewy Bodies
肽介导的反义寡核苷酸的新型全身递送治疗路易体痴呆
- 批准号:
10186335 - 财政年份:2021
- 资助金额:
$ 1.15万 - 项目类别:
Development of anti-sense oligonucleotides as a therapeutic for cancer pain through selective block of sodium channel pain targets
开发反义寡核苷酸通过选择性阻断钠通道疼痛靶标来治疗癌症疼痛
- 批准号:
10081895 - 财政年份:2020
- 资助金额:
$ 1.15万 - 项目类别:
Development of anti-sense oligonucleotides as a therapeutic for cancer pain through selective block of sodium channel pain targets
开发反义寡核苷酸通过选择性阻断钠通道疼痛靶标来治疗癌症疼痛
- 批准号:
10410515 - 财政年份:2020
- 资助金额:
$ 1.15万 - 项目类别:
Development of anti-sense oligonucleotides as a therapeutic for cancer pain through selective block of sodium channel pain targets
开发反义寡核苷酸通过选择性阻断钠通道疼痛靶标来治疗癌症疼痛
- 批准号:
10402419 - 财政年份:2020
- 资助金额:
$ 1.15万 - 项目类别:
Characterization of the function and regulation of long noncoding RNA Interferon gamma- anti-sense 1
长链非编码RNA干扰素γ-反义1的功能和调控的表征
- 批准号:
10026713 - 财政年份:2020
- 资助金额:
$ 1.15万 - 项目类别:
angiogenic therapy for cerebral infarction with anti^sense homology derived peptide targeting angiogenic factor
靶向血管生成因子的反义同源肽治疗脑梗死
- 批准号:
15K15523 - 财政年份:2015
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Functional analysis of anti-sense RNA and signal transduction in bacteria
细菌反义RNA和信号转导的功能分析
- 批准号:
25870115 - 财政年份:2013
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Studies on novel gene expression regulation system by anti-sense RNA in herpesvirus multiplication
疱疹病毒增殖中反义RNA新型基因表达调控系统的研究
- 批准号:
24658256 - 财政年份:2012
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Pediatric toxicity and efficacy in long-term systemic treatment with anti-sense
反义药物长期全身治疗的儿科毒性和疗效
- 批准号:
8338884 - 财政年份:2011
- 资助金额:
$ 1.15万 - 项目类别:














{{item.name}}会员




